Skip to main content
. 2020 Apr;9(4):2267–2279. doi: 10.21037/tcr.2020.03.43

Table 5. Univariate and multivariate logistic regression analysis were used to evaluate the relationship between the distant metastatic pattern and BCS.

Metastasis site/subtype Univariate analysis Multivariate analysis
Wald χ2 P OR (95% CI) P
Bone 19.788 <0.001*
   Her2+/HR+ vs. Her2−/HR+ 0.958 (0.426–4.143) 0.036*
   Her2+/HR− vs. Her2−/HR+ 0.296 (0.021–4.248) 0.027*
   TN vs. Her2−/HR+ 0.727 (0.155–3.419) 0.048*
   Her2+/HR+ vs. Her2+/HR− 4.273 (0.259–70.386) 0.310
   Her2+/HR+ vs. TN 1.826 (0.306–10.901) 0.509
   Her2+/HR− vs. TN 0.407 (0.023–7.131) 0.538
Lung 9.230 0.002*
   Her2+/HR+ vs. Her2−/HR+ 1.626 (0.650–4.063) 0.299
   Her2+/HR− vs. Her2−/HR+ 0.860 (0.067–10.977) 0.008*
   TN vs. Her2−/HR+ 2.075 (0.524–8.212) 0.298
   Her2+/HR+ vs. Her2+/HR− 2.114 (0.153–29.213) 0.576
   Her2+/HR+ vs. TN 0.784 (0.170–3.616) 0.755
   Her2+/HR− vs. TN 0.415 (0.027–6.299) 0.026*
Liver 62.243 <0.001*
   Her2+/HR+ vs. Her2−/HR+ 4.035 (0.968–16.827) 0.036*
   Her2+/HR− vs. Her2−/HR+ 7.100 (0.416–121.14) 0.046*
   TN vs. Her2−/HR+ 5.396 (0.889–32.755) 0.027*
   Her2+/HR+ vs. Her2+/HR− 0.259 (0.017–3.895) 0.858
   Her2+/HR+ vs. TN 0.748 (0.108–5.192) 0.769
   Her2+/HR− vs. TN 1.316 (0.074–23.431) 0.852
Brain 59.215 <0.001*
   Her2+/HR+ vs. Her2−/HR+ 9.991 (1.274–78.340) 0.028*
   Her2+/HR− vs. Her2−/HR+ NI NI
   TN vs. Her2−/HR+ 12.437 (0.967–159.880) 0.043*
   Her2+/HR+ vs. Her2+/HR− NI NI
   Her2+/HR+ vs. TN 0.803 (0.063–10.267) 0.866
   Her2+/HR− vs. TN NI NI

*, represent the P value <0.05. NI, not included in the multivariate logistic regression analysis.